Wei-Ting Liu Selected Research

Wei-Ting Liu Research Topics

Disease

6	Neoplasms (Cancer) 01/2019 - 02/2011
5	Glioma (Gliomas) 01/2016 - 02/2011
3	Inflammation (Inflammations) 08/2020 - 06/2010
2	Lung Neoplasms (Lung Cancer) 09/2012 - 05/2011
1	Chest Pain (Chest Pains) 01/2022
1	Lactic Acidosis 01/2022
1	Tuberculosis (Tuberculoses) 01/2022
1	Infections 01/2022
1	Dyspnea (Shortness of Breath) 01/2022
1	Dengue (Dengue Fever) 12/2021
1	Encephalitis (Encephalitis, Rasmussen) 01/2021
1	Communicable Diseases (Infectious Diseases) 01/2021
1	Chronic Obstructive Pulmonary Disease (COPD) 11/2020
1	Cardiovascular Diseases (Cardiovascular Disease) 11/2020
1	Coronary Artery Disease (Coronary Atherosclerosis) 11/2020
1	Diabetes Mellitus 11/2020
1	Hypertension (High Blood Pressure) 11/2020
1	Hyperalgesia 08/2020
1	Neuralgia (Stump Neuralgia) 08/2020
1	Glioblastoma (Glioblastoma Multiforme) 01/2016
1	Brain Neoplasms (Brain Tumor) 01/2016
1	Mouth Neoplasms (Oral Cancer) 01/2016
1	Neoplasm Metastasis (Metastasis) 01/2016
1	Ankylosing Spondylitis 04/2015
1	Nervous System Diseases (Neurological Disorders) 02/2011
1	Amebiasis (Amoebiasis) 06/2010
1	Acquired Immunodeficiency Syndrome (AIDS) 06/2009

Drug/Important Bio-Agent (IBA)

3	Minocycline (Cyclops)FDA LinkGeneric 01/2014 - 02/2011
2	Caspase 3 (Caspase-3)IBA 01/2016 - 01/2014
2	QuinazolinonesIBA 11/2014 - 01/2014
2	2- (naphthalene- 1- yl)- 6- pyrrolidinyl- 4- quinazolinoneIBA 11/2014 - 01/2014
1	Azithromycin (Zithromax)FDA LinkGeneric 01/2022
1	fibrin fragment D (D-dimer)IBA 01/2022
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2022
1	Linezolid (Zyvox)FDA Link 01/2022
1	decamethrin (deltamethrin)IBA 12/2021
1	Pyrethrins (Pyrethroids)FDA Link 12/2021
1	CalciumIBA 01/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	AcidsIBA 01/2021
1	chlorine dioxide (Alcide)IBA 01/2021
1	Hypochlorous Acid (Hypochlorite)IBA 01/2021
1	Disinfectants (Biocides)IBA 01/2021
1	Atorvastatin (Lipitor)FDA Link 11/2020
1	Rosuvastatin Calcium (Crestor)FDA Link 11/2020
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 11/2020
1	pitavastatin (itavastatin)FDA Link 11/2020
1	AcetoneIBA 08/2020
1	Glutamic Acid (Glutamate)FDA Link 08/2020
1	SolutionsIBA 08/2020
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 08/2020
1	Antidepressive Agents (Antidepressants)IBA 08/2020
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 11/2016
1	PyrrolesIBA 11/2016
1	indoleIBA 01/2016
1	Carbolines (Beta-Carbolines)IBA 01/2016
1	deguelinIBA 01/2016
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2016
1	NF-kappa B (NF-kB)IBA 01/2016
1	Monoclonal AntibodiesIBA 04/2015
1	HLA-B27 Antigen (HLA B27 Antigen)IBA 04/2015
1	Cyclin B1IBA 11/2014
1	7-hydroxystaurosporine (UCN 01)IBA 01/2014
1	Endoplasmic Reticulum Chaperone BiPIBA 09/2013
1	70-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 70 kDa)IBA 09/2013
1	Sirolimus (Rapamycin)FDA Link 09/2013
1	viequeamide AIBA 09/2012
1	veraguamide AIBA 05/2011
1	DepsipeptidesIBA 05/2011
1	3-methyladenineIBA 02/2011
1	divinyl sulfoneIBA 06/2010
1	Cysteine Proteases (Cysteine Protease)IBA 06/2010
1	EnzymesIBA 06/2010
1	Pharmaceutical PreparationsIBA 06/2009
1	Cyclic PeptidesIBA 06/2009

Therapy/Procedure

1	Kidney Transplantation 01/2022
1	Drug Therapy (Chemotherapy) 01/2016
1	Radiotherapy 01/2016